trial · primary record
Calaspargase pegol (S95015)
Acute Lymphoblastic Leukemia
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 42 |
| Primary completion | 2025-04-06 |
| Primary endpoint | Adverse Events (AEs) |
| Registry ID | NCT04817761 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:35.219Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04817761
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.